Detalles de la búsqueda
1.
Cancer-cell-secreted extracellular vesicles target p53 to impair mitochondrial function in muscle.
EMBO Rep
; 24(9): e56464, 2023 09 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439436
2.
The survival outcomes of prophylactic lateral neck dissection for medullary thyroid carcinoma, a retrospective cohort study.
Clin Otolaryngol
; 48(5): 734-739, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37366234
3.
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects.
BMC Cancer
; 22(1): 1116, 2022 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36319978
4.
Rho differentially regulates the Hippo pathway by modulating the interaction between Amot and Nf2 in the blastocyst.
Development
; 144(21): 3957-3967, 2017 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28947533
5.
Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.
Int J Clin Oncol
; 25(1): 59-66, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31414270
6.
C14orf93 (RTFC) is identified as a novel susceptibility gene for familial nonmedullary thyroid cancer.
Biochem Biophys Res Commun
; 482(4): 590-596, 2017 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27864143
7.
Publisher's Note: Rho differentially regulates the Hippo pathway by modulating the interaction between Amot and Nf2 in the blastocyst. Development doi: 10.1242/dev.157917.
Development
; 2017 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29025865
8.
An Inducible CRISPR-dCas9-Based Transcriptional Repression System for Cancer Therapy.
Small Methods
; : e2301310, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38164884
9.
Changes of biochemical factors and the effect on recurrence of medullary thyroid carcinoma after surgery.
Heliyon
; 10(8): e29857, 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38681571
10.
Multidimensional data analysis revealed thyroiditis-associated TCF19 SNP rs2073724 as a highly ranked protective variant in thyroid cancer.
Aging (Albany NY)
; 16(7): 6488-6509, 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38579171
11.
Breast cancer cell-secreted miR-199b-5p hijacks neurometabolic coupling to promote brain metastasis.
Nat Commun
; 15(1): 4549, 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38811525
12.
Dysregulation of miR-551b-5p and SETD2 Predicts Poor Prognosis and Promotes Migration and Invasion of Thyroid Cancers.
Endocr Metab Immune Disord Drug Targets
; 23(11): 1400-1409, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37073141
13.
Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer.
J Cancer
; 14(9): 1592-1604, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37325052
14.
Lnc-SNHG5 Promoted Hepatocellular Carcinoma Progression Through the RPS3-NFκB Pathway.
Int J Gen Med
; 16: 5651-5664, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38059157
15.
METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer.
Cell Death Differ
; 30(10): 2265-2279, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37648786
16.
Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.
PeerJ
; 11: e15025, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36935920
17.
Consistent analysis of differentially expressed genes across 7 cell types in papillary thyroid carcinoma.
Comput Struct Biotechnol J
; 21: 5337-5349, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37954148
18.
Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic-associated molecular subtypes and genomic mutations.
Front Pharmacol
; 14: 1224828, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37719859
19.
Partial preservation of the normal thyroid gland based on tumor diameter may be possible in small medullary thyroid carcinoma: a two-center 15-year retrospective study.
Front Oncol
; 13: 1216394, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37519823
20.
PARP inhibitor shuts down the global translation of thyroid cancer through promoting Pol II binding to DIMT1 pause.
Int J Biol Sci
; 19(12): 3970-3986, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37564214